Loading data
CRBUNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.16 m USD | 9.99 m USD | 34.48 m USD | 13.85 m USD | 9.6 m USD |
| Research and development expense | 109.44 m USD | 130.15 m USD | 112.08 m USD | 82.23 m USD | 52.26 m USD |
| Operating profit | -148.34 m USD | -166.62 m USD | -116.06 m USD | -106.4 m USD | -66.98 m USD |
| Profit before tax | -148.68 m USD | -149.11 m USD | -101.88 m USD | -99.35 m USD | -66.6 m USD |
| Income tax expense | -550 k USD | -9 k USD | 193 k USD | 70 k USD | 321 k USD |
| Net income (reported basis) | -148.1 m USD | -149.11 m USD | -102.07 m USD | -99.42 m USD | -66.92 m USD |
| Basic earnings per share | -1.59 USD/share | -1.65 USD/share | -1.38 USD/share | -1.64 USD/share | -2.11 USD/share |
| Diluted earnings per share | -1.59 USD/share | -1.65 USD/share | -1.38 USD/share | -1.64 USD/share | -2.11 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.